Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib in Osteoarthritis Patients with Inadequate Response to Analgesics (RESPOND-EUROPE)
NCT01429168Phase 4Withdrawn
- Sponsor
- Organon & Co.
- Start
- Oct 2011
- Primary completion
- Aug 2012
01
Overview
Phase 4, randomised, double-blind trial of etoricoxib in osteoarthritis (OA), sponsored by Organon & Co. Planned start Oct 2011; status: withdrawn.
02
Drugs
etoricoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01429168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01429168.